Ampio Pharmaceuticals Inc (NYSEAMERICAN:AMPE) shares were up 14.7% during trading on Friday . The company traded as high as $2.92 and last traded at $2.88. Approximately 3,389,460 shares were traded during mid-day trading, a decline of 18% from the average daily volume of 4,109,090 shares. The stock had previously closed at $2.51.
Separately, ValuEngine upgraded Ampio Pharmaceuticals from a “strong sell” rating to a “sell” rating in a research report on Wednesday, October 11th.
The firm has a market capitalization of $268.77, a PE ratio of -14.40 and a beta of 0.58.
About Ampio Pharmaceuticals
Ampio Pharmaceuticals, Inc is a biopharmaceutical company. The Company is focused primarily on the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options. The Company’s two lead product candidates in development are Ampion for osteoarthritis of the knee and Optina for diabetic macular edema.
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.